Professor Sandro Vento

All Stories

1. Article

   How to reduce HIV treatment default in sub-Saharan Africa.
   Professor Sandro Vento
2. Article

   HIV transmission in sub-Saharan Africa: too much importance has been given to vaginal sex.
   Professor Sandro Vento
3. Article

   COVID-19 mortality in Africa and Asia
   Professor Sandro Vento
4. Article

   Medical schools must be strongly improved in many low- and middle-income countries.
   Professor Sandro Vento
5. Article

   Advances in HIV Treatment: Long-Acting Antiretrovirals and the Path Toward a Cure
   Professor Sandro Vento
6. Article

   The Digital Health Competencies in Medical Education Framework
   Professor Sandro VentoProf. Dr. Mahmoud ElFiky
7. Article

   Short-Cycle Therapy with Bictegravir/Emtricitabine/Tenofovir Alafenamide in a Small Cohort of Virally Suppressed People Living with HIV: A Long-Term Follow-Up
   Professor Sandro Vento
8. Article

   Trends in publication and collaboration of health-themed systematic reviews before and during the COVID-19 pandemic: A bibliometric study
   Professor Yousef KhaderProfessor Sandro VentoDr. Robert Jeffrey Edwards

   (+1 more)

   James-Paul Kretchy
9. Article

   Acceptability of Switching to Long-Acting Cabotegravir and Rilpivirine Among People Living with HIV on Dolutegravir/Rilpivirine Combination: A Single-Center Experience
   Professor Sandro Vento
10. Article

    Overt and occult hepatitis B virus infection detected among chronic kidney disease patients on haemodialysis at a Tertiary Hospital in Ghana
    Professor Sandro Vento
11. Article

    Short Cycle, Intermittent Therapy: A Valuable Option in Selected, Virologically Suppressed People Living with HIV
    Professor Sandro Vento
12. Article

    Fulminant hepatitis in low- and middle-income countries.
    Professor Sandro Vento
13. Article

    HIV-1 RNA levels in semen of people on ‘short-cycle’ antiretroviral therapy
    Professor Sandro Vento
14. Article

    Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients
    Professor Sandro Vento
15. Article

    Serum 25‐hydroxyvitamin D and hyaluronic acid levels as markers of fibrosis in patients with chronic liver disease at the main tertiary referral hospital in Ghana: A case‐control study design
    Professor Sandro Vento
16. Article

    Medicine should be learned in a conducive environment
    Professor Sandro Vento
17. Article

    Global research profile on monkeypox-related literature (1962–2022): A bibliometric analysis
    Professor Sandro Vento
18. Article

    Monkeypox: Immune response, vaccination and preventive efforts
    Professor Sandro VentoDr. Seyi Samson Enitan Professor Yousef Khader

    (+2 more)

    Dr. Robert Jeffrey EdwardsDr. Ranjit Sah
19. Article

    Letter to the Editor: Dolutegravir Monotherapy and Body Weight Gain in Antiretroviral Naïve Patients
    Professor Sandro Vento
20. Article

    Acceptance and willingness to purchase a hypothetical COVID-19 vaccine in a region under Shariah law: A cross-sectional study in Aceh, Indonesia
    Professor Yousef KhaderProfessor Sandro VentoProf. Mudatsir, Mudatsir MMSc., PhD.

    (+1 more)

    Dr. Ranjit Sah
21. Article

    Acute severe hepatitis of unknown etiology in children: A mini-review
    Professor Yousef KhaderProfessor Sandro VentoJames-Paul Kretchy
22. Article

    Global multi-stakeholder endorsement of the MAFLD definition
    Dr Feliciano C PaquissiProfessor Sandro VentoDr. Francesca Cainelli

    (+5 more)

    Prof. Dr. Mahmoud ElFikyDr Arif Mansur CosarDr Amalia GastaldelliDr Nazarii KobyliakProf james O'Beirne
23. Article

    Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID‐19 infections?
    Professor Sandro Vento
24. Article

    Research priorities to reduce the impact of COVID-19 in low- and middle-income countries
    Professor Sandro VentoPrince PeprahDr. Giuseppe Lanza
25. Article

    Chronic liver diseases must be reduced worldwide: it is time to act
    Professor Sandro VentoDr. Francesca Cainelli
26. Article

    Seroprevalence and risk factors for hepatitis B and hepatitis C in three large regions of Kazakhstan
    Professor Sandro Vento
27. Article

    Short-cycle therapy in HIV-infected adults: rilpivirine combination 4 days on/3 days off therapy
    Professor Sandro Vento
28. Article

    Prevalence of liver fibrosis using transient elastography in the general population in Cambodia: a pilot study
    Professor Sandro VentoDr. Francesca Cainelli
29. Article

    Mini-review: Silico-tuberculosis
    Professor Sandro Vento
30. Article

    Short-cycle therapy (5 days on/2 days off) with a lamivudine + dolutegravir regimen in a cohort of virologically suppressed patients with HIV infection
    Professor Sandro Vento
31. Article

    Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor
    Professor Sandro Vento
32. Article

    Violence Against Healthcare Workers: A Worldwide Phenomenon With Serious Consequences
    Professor Sandro VentoDr. Francesca Cainelli
33. Article

    Acute liver failure
    Professor Sandro VentoDr. Francesca Cainelli
34. Article

    Commentary: Systemic Lupus Erythematosus in Native sub-Saharan Africans: A Systematic Review and Meta-Analysis
    Professor Sandro VentoDr. Francesca Cainelli
35. Article

    HIV and SARS-Coronavirus-2 Epidemics: Possible Interactions and Need for Studies, Especially in Africa
    Professor Sandro VentoDr. Francesca Cainelli
36. Article

    Seroprevalences of autoantibodies and anti-infectious antibodies among Ghana’s healthy population
    Professor Sandro Vento
37. Article

    Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
    Professor Sandro VentoDr. Francesca Cainelli
38. Article

    Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients
    Professor Sandro Vento
39. Article

    DRIVE-AHEAD Trial’s Results and the Need for a More Appropriate Comparator Drug
    Professor Sandro Vento
40. Article

    Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients
    Professor Sandro Vento
41. Article

    Orphan drugs
    Professor Sandro VentoDr. Francesca Cainelli
42. Article

    Khat-related liver disease in sub-Saharan Africa: neglected, yet important – Authors' reply
    Professor Sandro VentoDr. Francesca Cainelli
43. Article

    Patient-centered Care and Treatment in HIV Infection
    Professor Sandro Vento
44. Article

    Dolutegravir monotherapy: an option for highly adherent HIV1-infected naive patients with relatively low zenith HIV-RNA?
    Professor Sandro VentoSebastiano Rizzardo
45. Article

    Defensive medicine: It is time to finally slow down an epidemic
    Professor Sandro VentoDr. Francesca Cainelli
46. Article

    Liver cirrhosis in sub-Saharan Africa: neglected, yet important
    Professor Sandro VentoDr. Francesca Cainelli
47. Article

    “High” antiretroviral deintensification, a strategy to avoid drug interactions and unfavourable long-term effects of HAART
    Professor Sandro VentoSebastiano Rizzardo
48. Article

    Detection of Hepatitis E Antibodies in Kazakhstan: A Pilot Study
    Professor Sandro VentoDr. Francesca Cainelli
49. Article

    The Expanding Therapeutic Perspective of CCR5 Blockade
    Professor Sandro Vento
50. Article

    Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life
    Professor Sandro Vento
51. Article

    Febrile rhabdomyolysis of unknown origin in refugees coming from West Africa through the Mediterranean to Calabria, Italy
    Professor Sandro Vento
52. Article

    Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV ‐1‐infected patients
    Professor Sandro VentoFabio Rigo
53. Article

    Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up
    Professor Sandro Vento
54. Article

    Cerebral palsy: a multidisciplinary, integrated approach is essential
    Professor Sandro Vento
55. Article

    Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient
    Professor Sandro Vento
56. Article

    End-stage liver disease in eastern Europe and central Asia: action is needed
    Professor Sandro VentoDr. Francesca Cainelli
57. Article

    Treatment of Acute Liver Failure in Resource-Constrained Settings without Transplantation Facilities Can Be Improved
    Professor Sandro VentoDr. Francesca Cainelli
58. Article

    Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load
    Professor Sandro Vento
59. Article

    Tuberculosis-immune reconstitution inflammatory syndrome
    Professor Sandro Vento
60. Article

    Liver diseases in sub-Saharan Africa: the importance of dedicated public clinics
    Professor Sandro VentoDr. Francesca Cainelli
61. Article

    Understanding the HIV/AIDS Atripla drug components interaction with human plasma.
    Prof Kwenga Festus SichilongoSedireng Mompati NdoloProfessor Sandro Vento
62. Article

    Liver disease in patients with HIV in sub-Saharan Africa
    Professor Sandro VentoDr. Francesca Cainelli
63. Article

    Raltegravir/nevirapine dual therapy at reduced doses as ‘maintenance’ treatment in virally suppressed HIV-infected patients
    Professor Sandro Vento
64. Article

    Mother-to-child transmission of hepatitis B virus in sub-Saharan Africa: time to act
    Professor Sandro Vento
65. Article

    Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study
    Professor Sandro Vento
66. Article

    Virological Efficacy of a Reduced Dose of Nevirapine in a Small Cohort of Suppressed HIV-1–Infected Patients
    Professor Sandro Vento
67. Article

    Efficacy of a reduced dose of DARUNAVIR/RTV in a cohort of antiretroviral-naïve and experienced HIV-infected patients: a medium-term follow-up
    Professor Sandro Vento
68. Article

    Efavirenz dose reduction in HIV-infected patients
    Professor Sandro Vento
69. Article

    Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up
    Professor Sandro Vento
70. Article

    Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency
    Dr Antonio PicardiProfessor Sandro Vento
71. Article

    Management of chronic hepatitis B in children: An unresolved issue
    Professor Sandro VentoDr. Francesca Cainelli
72. Article

    Comparative chromatography–mass spectrometry studies on the antiretroviral drug nevirapine—Analytical performance characteristics in human plasma determination
    Prof Kwenga Festus SichilongoProfessor Sandro Vento
73. Article

    Thrombotic Thrombocytopenic Purpura-Haemolytic Uremic Syndrome and pregnancy
    Dr Julius C MwitaProfessor Sandro Vento
74. Article

    A Maintenance Dose of Atazanavir/Ritonavir 200/100 mg Once Daily Is Effective in Virologically Suppressed HIV-1–Infected Patients
    Professor Sandro Vento
75. Article

    Efficacy of a Reduced Dose of Darunavir/Ritonavir in a Small Cohort of Antiretroviral-Naïve HIV-Infected Patients
    Professor Sandro Vento
76. Article

    Cancer control in Africa: which priorities?
    Professor Sandro Vento
77. Article

    Limited Adherence to Antiretroviral Regimens in an Italian Cohort
    Professor Sandro VentoDr. Francesca Cainelli
78. Article

    Can HIV-1 viral interference be used therapeutically?
    Professor Sandro VentoDr. Francesca Cainelli
79. Article

    Dose reduction of antiretrovirals: a feasible and testable approach to expand HIV treatment in developing countries
    Professor Sandro VentoDr. Francesca Cainelli
80. Article

    Isoniazid preventive therapy in human immunodeficiency virus infection [Correspondence]
    Professor Sandro Vento
81. Article

    Efavirenz dose reduction in HIV-infected patients
    Professor Sandro Vento
82. Article

    Antiretroviral Therapy-Associated Diseases Are Common in the Long-Term
    Professor Sandro Vento
83. Article

    A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patients
    Professor Sandro Vento
84. Article

    Efficacy of Lopinavir-Ritonavir Reduced Dose in HIV-Infected Patients
    Professor Sandro Vento
85. Article

    Tuberculosis and cancer: a complex and dangerous liaison
    Professor Sandro Vento
86. Article

    Stroke: a realistic approach to a growing problem in sub-Saharan Africa is urgently needed
    Professor Sandro Vento
87. Article

    Can antiretroviral therapy be safely interrupted and, if so, when?
    Professor Sandro Vento
88. Article

    Silica Exposure and Silicosis: Action is Needed Now
    Professor Sandro VentoDr. Francesca Cainelli
89. Article

    Antiretroviral therapy in low-resource settings
    Professor Sandro VentoDr. Francesca Cainelli
90. Article

    Time for universal HIV and HBV screening for patients with cancer
    Professor Sandro VentoDr. Francesca Cainelli
91. Article

    Editorial: [Challenges in Infectious Diseases in Low and Middle-Income Countries]
    Professor Sandro Vento
92. Article

    The challenge of lymphomas in sub-Saharan Africa
    Professor Sandro VentoDr. Francesca Cainelli
93. Article

    PriorMycobacterium aviumcomplex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy
    Professor Sandro Vento
94. Article

    Lymph nodes and pathogenesis of infection with HIV-1
    Professor Sandro VentoDr. Francesca Cainelli
95. Article

    The need for new antibiotics
    Professor Sandro VentoDr. Francesca Cainelli
96. Article

    No Influence of Nevirapine on Vitamin D Deficiency in HIV-Infected Patients
    Professor Sandro Vento
97. Article

    The bacterium that could cause cancer
    Professor Sandro Vento
98. Article

    Diagnosis, management and outcome of clinically- suspected spinal infection
    Professor Sandro Vento
99. Article

    Maraviroc and CD4+ cell count recovery in patients with virologic suppression and blunted CD4+ cell response
    Professor Sandro Vento
100. Article

     Human herpesvirus type 6 hepatitis or familiar intrahepatic cholestasis: the importance of follow-up
     Professor Sandro Vento
101. Article

     Viral Encephalitis: Etiology, Clinical Features, Diagnosis and Management
     Professor Sandro VentoDr. Francesca Cainelli
102. Article

     Micafungin - The newest echinocandin
     Professor Sandro Vento
103. Article

     Letter to the Editor: Darunavir-Etravirine-Raltegravir as Salvage Combination Therapy in a Heavily Pretreated HIV-Infected Patient
     Professor Sandro Vento
104. Article

     Perspectives in therapy for hepatitis C
     Professor Sandro VentoDr. Francesca Cainelli
105. Article

     Lung infections after cancer chemotherapy
     Professor Sandro VentoDr. Francesca Cainelli
106. Article

     Aminotransferases as predictors of mortality
     Professor Sandro Vento
107. Article

     Does tenofovir increase efavirenz hepatotoxicity?
     Professor Sandro Vento
108. Article

     Initial Hospitalization and Adherence to Highly Active Antiretroviral Therapy
     Professor Sandro Vento
109. Article

     Voluntary or Universal HIV Testing in Italy?
     Professor Sandro Vento
110. Article

     Etravirine
     Professor Sandro Vento
111. Article

     Life-threatening, Multiple Hypersensitivity Reactions Induced by Rifampicin in One Patient with Pulmonary Tuberculosis
     Professor Sandro Vento
112. Article

     Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption
     Professor Sandro Vento
113. Article

     Selective Drug Taking During Combination Antiretroviral Therapy
     Professor Sandro Vento
114. Article

     Intracranial mass lesions in HIV/AIDS patients from developing countries endemic for neurocysticercosis
     Professor Sandro Vento
115. Article

     Approach to salvage antiretroviral therapy in heavily antiretroviral-experienced HIV-positive adults
     Professor Sandro VentoDr. Francesca Cainelli
116. Article

     Co-occurrence of chronic hepatitis B virus infection and autoimmune hepatitis in a young Senegalese girl
     Professor Sandro Vento
117. Article

     Tenofovir-Associated Kidney Diseases and Interactions between Tenofovir and Other Antiretrovirals
     Professor Sandro Vento
118. Article

     Infections and thalassaemia
     Professor Sandro VentoDr. Francesca Cainelli
119. Article

     Hyperacute Unilateral Gonococcal Endophthalmitis in an HIV-Infected Man without Genital Infection
     Professor Sandro Vento
120. Article

     Clinical course of infection with hepatitis C
     Professor Sandro VentoDr. Francesca Cainelli
121. Article

     Human Immunodeficiency Virus-Associated Peripheral Neuropathies
     Professor Sandro VentoDr. Francesca Cainelli
122. Article

     Interleukin-2 therapy and CD4+ T cells in HIV-1 infection
     Professor Sandro VentoDr. Francesca Cainelli
123. Article

     Acute liver failure as presenting feature of tyrosinemia type 1 in a child with primary HHV-6 infection
     Professor Sandro Vento
124. Article

     CHILDHOOD HEPATITIS C VIRUS INFECTION.
     Professor Sandro VentoDr. Francesca Cainelli
125. Article

     Recreational substance use and tolerance of efavirenz in HIV-1 infected patients
     Professor Sandro Vento
126. Article

     Cutaneous abscess due to in injection drug user: a case report and review of the literature
     Professor Sandro Vento
127. Article

     Strongyloidiasis in an HIV‐1–Infected Patient after Highly Active Antiretroviral Therapy–Induced Immune Restoration
     Professor Sandro Vento
128. Article

     Tipranavir
     Professor Sandro VentoDr. Francesca Cainelli
129. Article

     Antinuclear antibodies are common in an infectious environment but do not predict systemic lupus erythematosus
     Professor Sandro VentoDr. Francesca Cainelli
130. Article

     Can We Really Identify HIV-1 Long-Term Nonprogressors?
     Professor Sandro VentoDr. Francesca Cainelli
131. Article

     Painful Neuropathy Vasculitis in 2 Patients with Long-Standing Human Immunodeficiency Virus-1 Infection
     Professor Sandro Vento
132. Article

     Early detection of lung cancer in high-risk patients with HIV-1 infection
     Professor Sandro Vento
133. Article

     Autoimmune hemolytic anemia and autoimmune hepatitis associated with parvovirus B19 infection
     Professor Sandro Vento
134. Article

     Is there a role for viruses in triggering autoimmune hepatitis?
     Professor Sandro VentoDr. Francesca Cainelli
135. Article

     Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment
     Professor Sandro VentoDr. Francesca Cainelli
136. Article

     Is there a role for TNF-alpha in HIV1-associated lipodystrophy?
     Professor Sandro Vento
137. Article

     Unusual, rapidly growing ulcerative genital mass due to herpes simplex virus in a human immunodeficiency virus-infected woman
     Professor Sandro Vento
138. Article

     Management of Health Care Workers With Blood-Borne Infections
     Professor Sandro Vento
139. Article

     Hepatitis C virus in people with HIV infection
     Professor Sandro Vento
140. Article

     Blood-Borne Viruses and Health Care Workers
     Professor Sandro Vento
141. Article

     Sequelae and Serologic Outcome in Persons with Hepatitis B Virus Infection
     Professor Sandro VentoDr. Francesca Cainelli
142. Article

     Erratum
     Professor Sandro VentoDr. Francesca Cainelli
143. Article

     Infections and solid organ transplant rejection: a cause-and-effect relationship?
     Professor Sandro VentoDr. Francesca Cainelli
144. Article

     Hepatitis C is not a sexually transmissible disease
     Professor Sandro Vento
145. Article

     Long-term efficacy of dual nucleoside reverse transcriptase inhibitor antiretroviral therapy in HIV-1 infection
     Professor Sandro VentoDr. Francesca Cainelli
146. Article

     Treatment of autoantibody-associated chronic hepatitis C
     Professor Sandro Vento
147. Article

     Hepatitis C is not a sexually transmissible disease
     Professor Sandro VentoDr. Francesca Cainelli
148. Article

     Treatment of autoantibody-associated chronic hepatitis C
     Professor Sandro VentoDr. Francesca Cainelli
149. Article

     Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue
     Professor Sandro VentoDr. Francesca Cainelli
150. Article

     Childhood Infections and Autoimmune Diseases
     Professor Sandro VentoDr. Francesca Cainelli
151. Article

     Does hepatitis C virus cause severe liver disease only in people who drink alcohol?
     Professor Sandro VentoDr. Francesca Cainelli
152. Article

     How tainted is medicine?
     Professor Sandro Vento
153. Article

     Full Adherence to HAART: Is It Really Necessary?
     Professor Sandro VentoDr. Francesca Cainelli
154. Article

     BCG efficacy and tuberculin skin testing
     Professor Sandro VentoDr. Francesca Cainelli
155. Article

     A Case of Visceral Leishmaniasis with Protracted Incubation in a Nonendemic Area
     Professor Sandro VentoDr. Francesca Cainelli
156. Article

     Mortality Due to Hepatitis C Virus–Related Cirrhosis in Patients Infected with HIV Type 1: A Role for Alcohol
     Professor Sandro VentoDr. Francesca Cainelli
157. Article

     MHC Class I Molecules and Progression to AIDS
     Professor Sandro VentoDr. Francesca Cainelli
158. Article

     Hepatitis A Virus Infection and Atherosclerosis
     Professor Sandro VentoDr. Francesca Cainelli
159. Article

     Isolated Presence of Antibody to Hepatitis B Core Antigen in Injection Drug Users: Do They Need to Be Vaccinated?
     Professor Sandro Vento
160. Article

     Tuberculous chorioretinitis
     Professor Sandro Vento
161. Article

     Failure of lamivudine therapy for chemotherapy-induced reactivation of Hepatitis B
     Professor Sandro Vento
162. Article

     No Increase in Liver Decompensation Risk with Atypical Hepatitis C Virus Antibody Pattern
     Professor Sandro VentoDr. Francesca Cainelli
163. Article

     Failure of lamivudine therapy for chemotherapy-induced reactivation of Hepatitis B
     Professor Sandro VentoDr. Francesca Cainelli
164. Article

     HIV-1 progression in hepatitis-C-infected drug users
     Professor Sandro VentoDr. Vicente SorianoDr. Francesca Cainelli
165. Article

     Effect of pregnancy on chronic hepatitis C
     Professor Sandro VentoDr. Francesca Cainelli
166. Article

     Cryptococcal meningitis during cyclosporin treatment in a patient with psoriasis
     Professor Sandro VentoDr. Francesca Cainelli
167. Article

     Nosocomial Candidemia in Non-Neutropenic Patients at an Italian Tertiary Care Hospital
     Professor Sandro Vento
168. Article

     Coxsackie B virus-induced autoimmunity to GAD does not lead to type 1 diabetes
     Professor Sandro VentoDr. Francesca Cainelli
169. Article

     Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C
     Professor Sandro Vento
170. Article

     Recovery of long-term natural protection against reactivation of CMV retinitis in AIDS patients responding to highly active antiretroviral therapy
     Professor Sandro Vento
171. Article

     Mediastinal Lymphadenitis due To Cryptococcal Infection In HIV-Positive Patients On Highly Active Antiretroviral Therapy
     Professor Sandro Vento
172. Article

     Correspondence
     Professor Sandro Vento
173. Article

     Adherence to HAART in HIV
     Professor Sandro Vento
174. Article

     Failure of Prophylaxis against PCP in Patients with HIV Infection
     Professor Sandro Vento
175. Article

     Hepatitis Associated with Hepatitis A Superinfection in Patients with Chronic Hepatitis C
     Professor Sandro Vento
176. Article

     Response of uncomplicated falciparum malaria to oral chloroquine and quinine in Burundi highlands
     Professor Sandro Vento
177. Article

     Highly active antiretroviral therapy
     Professor Sandro Vento
178. Article

     Fluconazole penetration into the prostatic fluid of patients with AIDS- associated cryptococcal meningitis
     Professor Sandro Vento
179. Article

     Syphilis in prostitutes from Eastern Europe
     Professor Sandro Vento
180. Article

     Tuberculosis Among Refugees and Displaced People at the Burundi‐Rwanda Border
     Professor Sandro Vento
181. Article

     Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C
     Professor Sandro VentoDr. Francesca Cainelli
182. Article

     Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance
     Professor Sandro VentoDr. Francesca Cainelli
183. Article

     Microsporidium Species in Pulmonary Cavity Lesions of AIDS Patient Infected withRhodococcus equi
     Professor Sandro Vento
184. Article

     Comparative evaluation of naturally occurring Pneumocystis carinii pneumonia (PCP) and PCP despite primary chemoprophylaxis in patients with AIDS
     Professor Sandro Vento
185. Article

     The ParaSight™-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium falciparum malaria
     Professor Sandro Vento
186. Article

     Aetiology of pneumonia following isolated closed head injury
     Professor Sandro Vento
187. Article

     Steroid and interferon therapy in liver/kidney microsomal antibody-positive patients with chronic hepatitis C
     Professor Sandro VentoDr. Francesca Cainelli
188. Article

     Infection with hepatitis G virus in immunoglobulin recipients
     Professor Sandro Vento
189. Article

     M tuberculosis drug resistance in AIDS
     Professor Sandro Vento
190. Article

     Resolution of autoimmune hepatitis after bone-marrow transplantation
     Professor Sandro VentoDr. Francesca Cainelli
191. Article

     Twice-weekly dapsone for primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1 infection: efficacy, safety and pharmacokinetic data
     Professor Sandro Vento
192. Article

     Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patients
     Professor Sandro Vento
193. Article

     Lack of Sustained Efficacy of Interferon in Patients with Chronic Hepatitis C
     Professor Sandro Vento
194. Article

     Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus
     Professor Sandro VentoDr. Francesca Cainelli
195. Article

     Discordant Manifestations of Hepatitis C in Monozygotic Twins
     Professor Sandro Vento
196. Article

     Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals
     Professor Sandro VentoDr. Francesca Cainelli
197. Article

     Naturally acquired immunity to Plasmodium falciparum
     Professor Sandro Vento
198. Article

     Multidrug-Resistant Tuberculosis in Patients With AIDS
     Professor Sandro Vento
199. Article

     Multidrug-resistant tuberculosis in patients with AIDS
     Professor Sandro Vento
200. Article

     Pentoxifylline as a Supportive Agent in the Treatment of Cerebral Malaria in Children
     Professor Rocco MiccioloProfessor Sandro Vento
201. Article

     West African Immigrants and New Patterns of Malaria Imported to North Eastern Italy
     Professor Sandro Vento
202. Article

     Manifestations of TB to CD4 cell counts.
     Professor Sandro Vento
203. Article

     Prognosis of vertically transmitted pre-core mutant HBV infection
     Professor Sandro Vento
204. Article

     Pneumocystis carinii pneumonia during primary HIV-1 infection
     Professor Sandro Vento
205. Article

     Rapid decline of CD4+ cells after IFNα treatment in HIV-1 infection
     Professor Sandro Vento
206. Article

     Transmission of HIV-Associated Tuberculosis to Healthcare Workers
     Professor Rocco MiccioloProfessor Sandro Vento
207. Article

     Hepatitis C viraemia with normal liver histology in symptomless HIV-1 infection
     Professor Sandro Vento
208. Article

     Use of fluconazole in the treatment ofCandida albicans hydrocephalus shunt infection
     Professor Sandro Vento
209. Article

     Failure of the 12 months course of antituberculous chemoprophylaxis in HIV infection
     Professor Sandro Vento
210. Article

     Tuberculosis and HIV Infection
     Professor Sandro Vento
211. Article

     Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals
     Professor Sandro Vento
212. Article

     Survival after Active Tuberculosis in Patients with HIV Infection
     Professor Sandro Vento
213. Article

     Cellular mechanisms of hepatocyte damage and regulatory mechanisms in autoimmune chronic active hepatitis
     Professor Sandro Vento
214. Article

     Type 2 autoimmune hepatitis and hepatitis C virus infection
     Professor Sandro Vento
215. Article

     HAZARDS OF INTERFERON THERAPY FOR HBV-SERONEGATIVE CHRONIC HEPATITIS
     Professor Sandro Vento
216. Article

     REACTIVATION OF HEPATITIS B IN AIDS
     Professor Sandro Vento
217. Article

     CLINICAL REACTIVATION OF HEPATITIS B IN ANTI-HBs-POSITIVE PATIENTS WITH AIDS
     Professor Sandro Vento
218. Article

     PATHOGENESIS OF TYPE I DIABETES
     Professor Sandro Vento
219. Article

     Serial study of liver-directed autoantibodies and autoreactive T-lymphocytes in acute viral hepatitis B
     Professor Sandro Vento
220. Article

     Sequential studies of pre-S2 antigenemia and anti-pre-S2 antibodies in relation to viral replication in acute hepatitis B followed from the early incubation phase
     Professor Sandro Vento
221. Article

     In vitro effect of TP-1 (a calf thymic extract) on suppressor T-cell function of patients with autoimmune chronic active hepatitis
     Professor Sandro Vento
222. Article

     Relevance of immune mediated mechanisms in progressive alcoholic liver injury
     Professor Sandro Vento
223. Article

     PROSPECTIVE STUDY OF CELLULAR IMMUNITY TO HEPATITIS-B-VIRUS ANTIGENS FROM THE EARLY INCUBATION PHASE OF ACUTE HEPATITIS B
     Professor Sandro Vento
224. Article

     T-CELL INDUCERS OF SUPPRESSOR LYMPHOCYTES CONTROL LIVER-DIRECTED AUTOREACTIVITY
     Professor Sandro Vento
225. Article

     CELL-MEDIATED IMMUNITY AND SUPPRESSOR-T-CELL DEFECTS TO LIVER-DERIVED ANTIGENS IN FAMILIES OF PATIENTS WITH AUTOIMMUNE CHRONIC ACTIVE HEPATITIS
     Professor Sandro Vento
226. Article

     T lymphocyte sensitization to hbcag and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease
     Professor Sandro Vento
227. Article

     ANTIGEN SPECIFIC SUPPRESSOR CELL FUNCTION IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS
     Professor Sandro Vento